Literature DB >> 20454917

Structure and function of interleukin-22 and other members of the interleukin-10 family.

Daniela Barretto Barbosa Trivella1, José Ribamar Ferreira-Júnior, Laure Dumoutier, Jean-Christophe Renauld, Igor Polikarpov.   

Abstract

The IL-10 family of cytokines is comprised of IL-10, IL-19, IL-20, IL-22, IL-24, IL-26, and IFN-lambdas (IL-28A, IL-28B, and IL-29). The IL-10 family members bind to shared class II cytokine receptor chains that associate in various combinations in heterodimeric complexes. Upon interleukin/receptor complex formation, these proteins switch on the Jak/STAT pathway and elicit pleiotropic biological responses whose variety sharply contrasts with their structural similarities. IL-10 family members are involved in several human diseases and health conditions and hence their structural analyses may provide valuable information to design specific therapeutic strategies. In this review, we describe the human interleukin-10 family of cytokines, focusing on their structures and functions, with particular attention given to IL-22 and IL-10. We report on the recently published structures of IL-10 cytokine family members and their complexes with cognate transmembrane and soluble receptors as well as on interleukin physiology and physiopathology.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20454917     DOI: 10.1007/s00018-010-0380-0

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  170 in total

1.  IL-28, IL-29 and their class II cytokine receptor IL-28R.

Authors:  Paul Sheppard; Wayne Kindsvogel; Wenfeng Xu; Katherine Henderson; Stacy Schlutsmeyer; Theodore E Whitmore; Rolf Kuestner; Ursula Garrigues; Carl Birks; Jenny Roraback; Craig Ostrander; Dennis Dong; Jinu Shin; Scott Presnell; Brian Fox; Betty Haldeman; Emily Cooper; David Taft; Teresa Gilbert; Francis J Grant; Monica Tackett; William Krivan; Gary McKnight; Chris Clegg; Don Foster; Kevin M Klucher
Journal:  Nat Immunol       Date:  2002-12-02       Impact factor: 25.606

Review 2.  Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. A consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS).

Authors:  U Plöckinger; G Rindi; R Arnold; B Eriksson; E P Krenning; W W de Herder; A Goede; M Caplin; K Oberg; J C Reubi; O Nilsson; G Delle Fave; P Ruszniewski; H Ahlman; B Wiedenmann
Journal:  Neuroendocrinology       Date:  2005-04-18       Impact factor: 4.914

Review 3.  MDA-7/IL-24: novel cancer growth suppressing and apoptosis inducing cytokine.

Authors:  Moira Sauane; Rahul V Gopalkrishnan; Devanand Sarkar; Zao Zhong Su; Irina V Lebedeva; Paul Dent; Sidney Pestka; Paul B Fisher
Journal:  Cytokine Growth Factor Rev       Date:  2003-02       Impact factor: 7.638

4.  Interleukin 20: discovery, receptor identification, and role in epidermal function.

Authors:  H Blumberg; D Conklin; W F Xu; A Grossmann; T Brender; S Carollo; M Eagan; D Foster; B A Haldeman; A Hammond; H Haugen; L Jelinek; J D Kelly; K Madden; M F Maurer; J Parrish-Novak; D Prunkard; S Sexson; C Sprecher; K Waggie; J West; T E Whitmore; L Yao; M K Kuechle; B A Dale; Y A Chandrasekher
Journal:  Cell       Date:  2001-01-12       Impact factor: 41.582

5.  Human IL-19 regulates immunity through auto-induction of IL-19 and production of IL-10.

Authors:  William J Jordan; Joyce Eskdale; Michele Boniotto; Greig P Lennon; Jon Peat; John D M Campbell; Grant Gallagher
Journal:  Eur J Immunol       Date:  2005-05       Impact factor: 5.532

6.  Jalview Version 2--a multiple sequence alignment editor and analysis workbench.

Authors:  Andrew M Waterhouse; James B Procter; David M A Martin; Michèle Clamp; Geoffrey J Barton
Journal:  Bioinformatics       Date:  2009-01-16       Impact factor: 6.937

7.  Epidermal overexpression of interleukin-19 and -20 mRNA in psoriatic skin disappears after short-term treatment with cyclosporine a or calcipotriol.

Authors:  John Rømer; Erik Hasselager; Peder Lisby Nørby; Torben Steiniche; Jes Thorn Clausen; Knud Kragballe
Journal:  J Invest Dermatol       Date:  2003-12       Impact factor: 8.551

8.  Comparison of interleukin-22 and interleukin-10 soluble receptor complexes.

Authors:  Naomi J Logsdon; Brandi C Jones; Kristopher Josephson; Jennifer Cook; Mark R Walter
Journal:  J Interferon Cytokine Res       Date:  2002-11       Impact factor: 2.607

9.  Melanoma differentiation associated gene-7/interleukin-24 promotes tumor cell-specific apoptosis through both secretory and nonsecretory pathways.

Authors:  Moira Sauane; Irina V Lebedeva; Zao-zhong Su; Heng-tong Choo; Aaron Randolph; Kristoffer Valerie; Paul Dent; Rahul V Gopalkrishnan; Paul B Fisher
Journal:  Cancer Res       Date:  2004-05-01       Impact factor: 12.701

10.  Characterization of the recombinant extracellular domains of human interleukin-20 receptors and their complexes with interleukin-19 and interleukin-20.

Authors:  Sergei Pletnev; Eugenia Magracheva; Serguei Kozlov; Gregory Tobin; Sergei V Kotenko; Alexander Wlodawer; Alexander Zdanov
Journal:  Biochemistry       Date:  2003-11-04       Impact factor: 3.162

View more
  14 in total

1.  Myeloid cells migrate in response to IL-24.

Authors:  Krisztina Buzas; Joost J Oppenheim; O M Zack Howard
Journal:  Cytokine       Date:  2011-06-23       Impact factor: 3.861

2.  A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus.

Authors:  Ludmila Prokunina-Olsson; Brian Muchmore; Wei Tang; Ruth M Pfeiffer; Heiyoung Park; Harold Dickensheets; Dianna Hergott; Patricia Porter-Gill; Adam Mumy; Indu Kohaar; Sabrina Chen; Nathan Brand; McAnthony Tarway; Luyang Liu; Faruk Sheikh; Jacquie Astemborski; Herbert L Bonkovsky; Brian R Edlin; Charles D Howell; Timothy R Morgan; David L Thomas; Barbara Rehermann; Raymond P Donnelly; Thomas R O'Brien
Journal:  Nat Genet       Date:  2013-01-06       Impact factor: 38.330

3.  In vivo consequences of liver-specific interleukin-22 expression in mice: Implications for human liver disease progression.

Authors:  Ogyi Park; Hua Wang; Honglei Weng; Lionel Feigenbaum; Hai Li; Shi Yin; Sung Hwan Ki; Seong Ho Yoo; Steven Dooley; Fu-Sheng Wang; Howard A Young; Bin Gao
Journal:  Hepatology       Date:  2011-07       Impact factor: 17.425

4.  IL-22 is expressed by the invasive trophoblast of the equine (Equus caballus) chorionic girdle.

Authors:  Margaret M Brosnahan; Donald C Miller; Mackenzie Adams; Douglas F Antczak
Journal:  J Immunol       Date:  2012-04-04       Impact factor: 5.422

Review 5.  The molecular basis of IL-10 function: from receptor structure to the onset of signaling.

Authors:  Mark R Walter
Journal:  Curr Top Microbiol Immunol       Date:  2014       Impact factor: 4.291

6.  The crystal structure of zebrafish IL-22 reveals an evolutionary, conserved structure highly similar to that of human IL-22.

Authors:  P Siupka; O J Hamming; M Frétaud; G Luftalla; J-P Levraud; R Hartmann
Journal:  Genes Immun       Date:  2014-05-15       Impact factor: 2.676

7.  The Role of Interleukin-22 and Its Receptor in the Development and Pathogenesis of Experimental Autoimmune Uveitis.

Authors:  Yejin Kim; Tae Wan Kim; Yun Seong Park; Eui Man Jeong; Dong-Sup Lee; In-Gyu Kim; Hum Chung; Young-Il Hwang; Wang Jae Lee; Hyeong Gon Yu; Jae Seung Kang
Journal:  PLoS One       Date:  2016-05-11       Impact factor: 3.240

8.  The cationic cytokine IL-26 differentially modulates virus infection in culture.

Authors:  Oliver Braum; Michael Klages; Helmut Fickenscher
Journal:  PLoS One       Date:  2013-07-10       Impact factor: 3.240

9.  Impact of the New Generation Reconstituted Surfactant CHF5633 on Human CD4+ Lymphocytes.

Authors:  Markus Fehrholz; Kirsten Glaser; Silvia Seidenspinner; Barbara Ottensmeier; Tore Curstedt; Christian P Speer; Steffen Kunzmann
Journal:  PLoS One       Date:  2016-04-14       Impact factor: 3.240

10.  Comparison of the pathogen species-specific immune response in udder derived cell types and their models.

Authors:  Juliane Günther; Mirja Koy; Anne Berthold; Hans-Joachim Schuberth; Hans-Martin Seyfert
Journal:  Vet Res       Date:  2016-02-01       Impact factor: 3.683

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.